59 related articles for article (PubMed ID: 15150013)
1. PET-CT of extranodal lymphoma.
Metser U; Goor O; Lerman H; Naparstek E; Even-Sapir E
AJR Am J Roentgenol; 2004 Jun; 182(6):1579-86. PubMed ID: 15150013
[No Abstract] [Full Text] [Related]
2. 2-(fluorine-18)fluoro-2-deoxy-D-glucose positron emission tomography in the detection and staging of malignant lymphoma. A bicenter trial.
Buchmann I; Reinhardt M; Elsner K; Bunjes D; Altehoefer C; Finke J; Moser E; Glatting G; Kotzerke J; Guhlmann CA; Schirrmeister H; Reske SN
Cancer; 2001 Mar; 91(5):889-99. PubMed ID: 11251940
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic accuracy of PET/CT in patients with extranodal marginal zone MALT lymphoma.
Perry C; Herishanu Y; Metzer U; Bairey O; Ruchlemer R; Trejo L; Naparstek E; Sapir EE; Polliack A
Eur J Haematol; 2007 Sep; 79(3):205-9. PubMed ID: 17662066
[TBL] [Abstract][Full Text] [Related]
4. [PET-CT with intravenous contrast in the evaluation of patients with lymphoma. Contribution to diagnostic indications].
Talavera Rubio MP; García Vicente AM; Domínguez Ferreras E; Calle Primo C; Poblete García VM; Hernández Ruiz B; Bellón Guardia M; Palomar Muñoz A; Cepedello Boiso I; Pilkington Woll P; González García B; Cordero García JM; Molino Trinidad C; Soriano Castrejón A
Rev Esp Med Nucl; 2009; 28(5):235-41. PubMed ID: 19922840
[TBL] [Abstract][Full Text] [Related]
5. Comparison of 18F-FDG positron emission tomography and computed tomography in patients with colorectal carcinoma and lymphoma: our initial clinical experience.
Coha B; Radmilović K; Gardasanić J; Daković M; Stefanić M; Latić A; Mitrecić D
Acta Clin Croat; 2009 Mar; 48(1):35-9. PubMed ID: 19623870
[TBL] [Abstract][Full Text] [Related]
6. The management of pyothorax-associated lymphoma using 18F-FDG PET/CT.
Ito K; Shida Y; Kubota K; Morooka M; Aruga T; Itami J; Matsuda H
Ann Nucl Med; 2010 Nov; 24(9):649-54. PubMed ID: 20740330
[TBL] [Abstract][Full Text] [Related]
7. 18F-FDG PET and PET/CT in Burkitt's lymphoma.
Karantanis D; Durski JM; Lowe VJ; Nathan MA; Mullan BP; Georgiou E; Johnston PB; Wiseman GA
Eur J Radiol; 2010 Jul; 75(1):e68-73. PubMed ID: 19716248
[TBL] [Abstract][Full Text] [Related]
8. Newly diagnosed lymphoma: initial results with whole-body T1-weighted, STIR, and diffusion-weighted MRI compared with 18F-FDG PET/CT.
van Ufford HM; Kwee TC; Beek FJ; van Leeuwen MS; Takahara T; Fijnheer R; Nievelstein RA; de Klerk JM
AJR Am J Roentgenol; 2011 Mar; 196(3):662-9. PubMed ID: 21343511
[TBL] [Abstract][Full Text] [Related]
9. Differential diagnosis of primary nasopharyngeal lymphoma and nasopharyngeal carcinoma focusing on CT, MRI, and PET/CT.
Cho KS; Kang DW; Kim HJ; Lee JK; Roh HJ
Otolaryngol Head Neck Surg; 2012 Apr; 146(4):574-8. PubMed ID: 22261493
[TBL] [Abstract][Full Text] [Related]
10. Extranodal lymphoma in the thorax: cross-sectional imaging findings.
Lee WK; Duddalwar VA; Rouse HC; Lau EW; Bekhit E; Hennessy OF
Clin Radiol; 2009 May; 64(5):542-9. PubMed ID: 19348852
[TBL] [Abstract][Full Text] [Related]
11. FDG PET-CT in the management of primary breast lymphoma.
Santra A; Kumar R; Reddy R; Halanaik D; Kumar R; Bal CS; Malhotra A
Clin Nucl Med; 2009 Dec; 34(12):848-53. PubMed ID: 20139815
[TBL] [Abstract][Full Text] [Related]
12. Prospective study of bone marrow infiltration in aggressive lymphoma by three independent methods: whole-body MRI, PET/CT and bone marrow biopsy.
Ribrag V; Vanel D; Leboulleux S; Lumbroso J; Couanet D; Bonniaud G; Aupérin A; Masson F; Bosq J; Edeline V; Fermé C; Pigneur F; Schlumberger M
Eur J Radiol; 2008 May; 66(2):325-31. PubMed ID: 17651934
[TBL] [Abstract][Full Text] [Related]
13. Whole-body MRI, including diffusion-weighted imaging, for the initial staging of malignant lymphoma: comparison to computed tomography.
Kwee TC; van Ufford HM; Beek FJ; Takahara T; Uiterwaal CS; Bierings MB; Ludwig I; Fijnheer R; Nievelstein RA
Invest Radiol; 2009 Oct; 44(10):683-90. PubMed ID: 19724232
[TBL] [Abstract][Full Text] [Related]
14. Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography.
Lardinois D; Weder W; Hany TF; Kamel EM; Korom S; Seifert B; von Schulthess GK; Steinert HC
N Engl J Med; 2003 Jun; 348(25):2500-7. PubMed ID: 12815135
[TBL] [Abstract][Full Text] [Related]
15. Characterization of T-cell lymphomas by FDG PET/CT.
Feeney J; Horwitz S; Gönen M; Schöder H
AJR Am J Roentgenol; 2010 Aug; 195(2):333-40. PubMed ID: 20651187
[TBL] [Abstract][Full Text] [Related]
16. Marginal zone lymphoma involving subcutaneous fat: appearance by FDG-PET/CT, MRI, and contrast-enhanced CT imaging.
Chong EA; Torigian DA; Mato AR; Downs LH; Schuster SJ
Clin Nucl Med; 2008 Oct; 33(10):692-3. PubMed ID: 18806570
[No Abstract] [Full Text] [Related]
17. PET scanning.
Miles KA
BMJ; 1989 Apr; 298(6681):1177. PubMed ID: 2500181
[No Abstract] [Full Text] [Related]
18. Primary Testicular Non-Hodgkin's Lymphoma With Bilateral Adrenal Metastasis: A Rare Presentation.
Mane S; Phatak S; Dhok A; Shaikh AS
Cureus; 2023 Aug; 15(8):e43766. PubMed ID: 37727197
[TBL] [Abstract][Full Text] [Related]
19. Histopathological Experience of Primary Adrenal Lymphoma From Two Tertiary Hospitals.
Al-Maghrabi J
Cureus; 2023 Aug; 15(8):e42940. PubMed ID: 37667690
[TBL] [Abstract][Full Text] [Related]
20. [18F]FDG PET/CT and PET/MR in Patients with Adrenal Lymphoma: A Systematic Review of Literature and a Collection of Cases.
Evangelista L; Crimì F; Visentin A; Voltan G; Trentin L; Lacognata C; Cecchin D; Ceccato F
Curr Oncol; 2022 Oct; 29(10):7887-7899. PubMed ID: 36290900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
